Monoclonal antibodies: A potentially powerful tool in the diagnosis and treatment of infectious diseases

G. Spira; R. R. Pollock; A. Bargellesi; M. D. Scharff

doi:10.1007/BF02013647

Monoclonal antibodies: A potentially powerful tool in the diagnosis and treatment of infectious diseases

G. Spira, R. R. Pollock, A. Bargellesi, M. D. Scharff

Cell Biology

Research output: Contribution to journal › Editorial › peer-review

5 Scopus citations

Abstract

The hybridoma technology has made it possible to generate superior serological reagents in large amounts and to have the same reagents available indefinitely. Such monoclonal antibodies are very useful in diagnosis and epidemiology. Monoclonals have also made it possible to identify the sequences on infectious agents that are responsible for their infectivity and to generate and study both polypeptide and idiotypic vaccines. Once human monoclonals can be easily generated and produced, passive immunization may again become a major therapeutic tool.

Original language	English (US)
Pages (from-to)	251-256
Number of pages	6
Journal	European Journal of Clinical Microbiology
Volume	4
Issue number	3
DOIs	https://doi.org/10.1007/BF02013647
State	Published - Jun 1985

ASJC Scopus subject areas

Microbiology
Microbiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/BF02013647

Cite this

@article{54f11717012343ed996c6afd6b29affd,

title = "Monoclonal antibodies: A potentially powerful tool in the diagnosis and treatment of infectious diseases",

abstract = "The hybridoma technology has made it possible to generate superior serological reagents in large amounts and to have the same reagents available indefinitely. Such monoclonal antibodies are very useful in diagnosis and epidemiology. Monoclonals have also made it possible to identify the sequences on infectious agents that are responsible for their infectivity and to generate and study both polypeptide and idiotypic vaccines. Once human monoclonals can be easily generated and produced, passive immunization may again become a major therapeutic tool.",

author = "G. Spira and Pollock, {R. R.} and A. Bargellesi and Scharff, {M. D.}",

year = "1985",

month = jun,

doi = "10.1007/BF02013647",

language = "English (US)",

volume = "4",

pages = "251--256",

journal = "European Journal of Clinical Microbiology",

issn = "0722-2211",

publisher = "Vieweg",

number = "3",

}

TY - JOUR

T1 - Monoclonal antibodies

T2 - A potentially powerful tool in the diagnosis and treatment of infectious diseases

AU - Spira, G.

AU - Pollock, R. R.

AU - Bargellesi, A.

AU - Scharff, M. D.

PY - 1985/6

Y1 - 1985/6

N2 - The hybridoma technology has made it possible to generate superior serological reagents in large amounts and to have the same reagents available indefinitely. Such monoclonal antibodies are very useful in diagnosis and epidemiology. Monoclonals have also made it possible to identify the sequences on infectious agents that are responsible for their infectivity and to generate and study both polypeptide and idiotypic vaccines. Once human monoclonals can be easily generated and produced, passive immunization may again become a major therapeutic tool.

AB - The hybridoma technology has made it possible to generate superior serological reagents in large amounts and to have the same reagents available indefinitely. Such monoclonal antibodies are very useful in diagnosis and epidemiology. Monoclonals have also made it possible to identify the sequences on infectious agents that are responsible for their infectivity and to generate and study both polypeptide and idiotypic vaccines. Once human monoclonals can be easily generated and produced, passive immunization may again become a major therapeutic tool.

UR - http://www.scopus.com/inward/record.url?scp=0022262941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022262941&partnerID=8YFLogxK

U2 - 10.1007/BF02013647

DO - 10.1007/BF02013647

M3 - Editorial

C2 - 2410264

AN - SCOPUS:0022262941

SN - 0722-2211

VL - 4

SP - 251

EP - 256

JO - European Journal of Clinical Microbiology

JF - European Journal of Clinical Microbiology

IS - 3

ER -

Monoclonal antibodies: A potentially powerful tool in the diagnosis and treatment of infectious diseases

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this